A GPX4-targeted photosensitizer, by integrating ML210 with photodynamic therapy, reverses the hypoxic tumor microenvironment’s inhibition of ferroptosis for non-small-cell lung cancer therapy [66]. The gene discussed is GPX4; the disease is neoplasm.